Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone

PHASE3CompletedINTERVENTIONAL
Enrollment

267

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Schizophrenia
Interventions
DRUG

Blonanserin

Blonanserin tablets: 8 - 24mg/day; twice daily after breakfast and dinner; in the meantime, the placebo and positive drug were taken in whole tablets. When the morning and evening doses could not be administered equally, the evening dose should be greater than the morning dose. The interval between 2 dose escalations should not be shorter than 3 days.

DRUG

Risperidone

Risperidone tablets: 2 - 6mg/day; twice daily after breakfast and dinner; in the meantime, the placebo and positive drug were taken in whole tablets. When the morning and evening doses could not be administered equally, the evening dose should be greater than the morning dose. The interval between 2 dose escalations should not be shorter than 3 days.

Trial Locations (16)

100088

Beijing Anding Hospital, Beijing

100096

Beijing Huilongguan Hospital, Beijing

100191

Peking University Sixth Hospital, Beijing

150001

The First Affiliated Hospital of Harbin Medical University, Harbin

200030

Shanghai Mental Health Center, Shanghai

210029

Nanjing Brain Hospital, Nanjing

214000

Wuxi Mental Health Center, Wuxi

300222

Tianjin Anding Hospital, Tianjin

410000

The Second Xiangya Hospital of Central South University, Changsha

410007

Hunan Province Brain Hospital, Changsha

453002

Henan Provincial Mental Hospital, Xinxiang

510170

Guangzhou Brain Hospital, Guangzhou

610041

West China Hospital, Sichuan University, Chengdu

650032

First Affiliated Hospital of Kunming Medical University, Kunming

710061

Xi'an Mental Health Center, Xi’an

071000

Hebei Province Mental Health Center, Baoding

All Listed Sponsors
lead

Sumitomo Pharma (Suzhou) Co., Ltd.

INDUSTRY

NCT01516424 - Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone | Biotech Hunter | Biotech Hunter